Shanda Group

Xunlu AI is an innovative startup that focuses on the development of AI-powered customer service technologies. Xunlu AI provides AI intelligent customer service and sales robots to businesses in a variety of industries via highly tailored AI solutions, assisting businesses in achieving their goals of cost reduction and increased productivity.

Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing therapies that target senescent cells responsible for various age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of innovative therapeutic candidates. These candidates include novel small molecules designed to selectively address senescent cells, which contribute to the progression of several chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises experienced professionals from the fields of chemistry, technology, and life sciences, bringing a wealth of knowledge in drug development and commercialization.

Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.

DigiFT Tech is focused on providing regulated decentralized finance solutions on the Ethereum public blockchain. The company operates a digital asset exchange that is compliant with regulatory standards, allowing asset owners to issue blockchain-based security tokens. This platform facilitates trading for investors, offering continuous liquidity through an Automatic Market Maker mechanism. Additionally, DigiFT's platform enables users to trade decentralized finance products using fiat currency, and it supports fund transfers to various wallets. Overall, DigiFT aims to create a secure and compliant environment for blockchain trading.

Jimeng Intelligent is a technology-driven company specializing in the industrial Internet sector, focusing on the manufacturing industry. It has developed a comprehensive digital factory platform that incorporates extensive data storage and advanced analytical frameworks. This platform enables real-time monitoring of various factors in the manufacturing process, including equipment status, environmental conditions, and staffing capacity. By utilizing machine learning and big data visualization, Jimeng Intelligent provides insights through data mining and analysis, allowing clients to achieve adaptive control and enhance operational efficiency. The company's offerings aim to meet the digital and intelligent needs of modern manufacturing facilities.

Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.

WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.

Socialtrait is a company that specializes in developing AI-powered solutions aimed at predicting, measuring, and enhancing the effectiveness of brand concepts. Its platform provides a range of tools that facilitate reputation risk management, audience insights, competitive analysis, and rapid A/B testing. By leveraging these tools, brands can make informed decisions regarding their content strategies, ultimately driving greater engagement and success.

Turn.bio is a biotechnology company focused on developing drugs aimed at reversing aging and age-related diseases. Leveraging its patented mRNA platform technology, known as ERA, the company addresses the effects of aging on the epigenome, thereby restoring optimal gene expression. Turn.bio’s innovative approach enables the body to heal itself by instructing specific cells to combat diseases or repair damaged tissues. The company targets a range of medical indications, including immune-related diseases such as cancer, dermatological conditions, ophthalmology, osteoarthritis, and issues related to the muscular system. Through its advanced delivery platform, eTurna, Turn.bio seeks to enhance the effectiveness of nucleic acid therapeutics in promoting health and longevity.

WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.

Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Ombre is a provider of microbiome testing kits that focus on personalized health solutions. The company offers subscription-based services that include customized microbiome testing and probiotics tailored to individual needs. Through its testing kits, Ombre delivers actionable insights aimed at preventing chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By addressing the root causes of gut-related issues, Ombre empowers customers to improve their overall health and well-being with science-backed interventions.

Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.

Turn.bio is a biotechnology company focused on developing drugs aimed at reversing aging and age-related diseases. Leveraging its patented mRNA platform technology, known as ERA, the company addresses the effects of aging on the epigenome, thereby restoring optimal gene expression. Turn.bio’s innovative approach enables the body to heal itself by instructing specific cells to combat diseases or repair damaged tissues. The company targets a range of medical indications, including immune-related diseases such as cancer, dermatological conditions, ophthalmology, osteoarthritis, and issues related to the muscular system. Through its advanced delivery platform, eTurna, Turn.bio seeks to enhance the effectiveness of nucleic acid therapeutics in promoting health and longevity.

Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing therapies that target senescent cells responsible for various age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of innovative therapeutic candidates. These candidates include novel small molecules designed to selectively address senescent cells, which contribute to the progression of several chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises experienced professionals from the fields of chemistry, technology, and life sciences, bringing a wealth of knowledge in drug development and commercialization.

PhaseShift Technologies is addressing the critical need for new materials that can overcome limitations in performance, efficiency, cost, availability, and sustainability. Traditional material development relies heavily on trial-and-error, requiring costly and time-consuming physical experiments. This approach can extend projects over 10-20 years and cost millions of dollars, with no guarantee of success. PhaseShift's Rapid Alloy Design (RAD)™ technology revolutionizes this process by using AI to create optimized alloys tailored to specific use cases. Paired with Multi-Scale Simulations to accurately predict material performance, RAD™ minimizes the time and effort spent on unsuccessful trials. This leads to faster, more efficient development cycles and a significant reduction in resources required to meet design goals. Through the RAD™ platform, PhaseShift designs a portfolio of innovative alloys, which are commercialized via strategic partnerships with manufacturers.

Vectorly Inc. operates a video learning platform tailored for companies and students, enhancing the educational experience through technology. Founded in 2015 and based in New York, with an additional office in Bengaluru, India, Vectorly specializes in AI-based video enhancement. The company's patented technology allows for real-time upscale and enhancement of video on users' devices, ensuring smooth and high-quality viewing experiences across various network connections. This innovation helps reduce bandwidth usage and buffer times, making it suitable for streaming platforms looking to minimize cloud storage and delivery costs. Formerly known as Dot Learn Inc., Vectorly rebranded in 2018 and was acquired by Hopin in December 2021.

Iota Biosciences, Inc. is a medical device company based in Berkeley, California, founded in 2017. It specializes in the development of wireless sensors and devices aimed at monitoring, measuring, and stimulating internal nerves, muscles, and organs for electroceutical applications, particularly in the treatment of immune and neural disorders. The company has pioneered neural dust technology, utilizing implantable, mote-sized ultrasonic sensors that enable untethered and real-time wireless cortical recordings, improving the methods by which physicians monitor and treat various diseases. Iota's mission is to create safe and effective bioelectronic devices that transform disease management and enhance patient care. As a subsidiary of Astellas Pharma, Iota is committed to leveraging innovative science and technology to advance the field of bioelectronics and make a meaningful impact on patients' lives.

Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.

Krisp develops an AI-powered application that enhances audio quality for remote workers by eliminating background noise and improving voice clarity during calls. The app integrates seamlessly with various conferencing and recording platforms and is compatible with all types of headsets and microphones, including built-in, Bluetooth, and USB devices. Krisp's technology not only cancels unwanted noise but also recovers lost sound packets during network transfers, transforming low-bitrate audio into high-definition quality. This makes it particularly useful for contact centers, telecommunications, and critical communication scenarios, ensuring clear and professional audio in a variety of settings.

Ombre is a provider of microbiome testing kits that focus on personalized health solutions. The company offers subscription-based services that include customized microbiome testing and probiotics tailored to individual needs. Through its testing kits, Ombre delivers actionable insights aimed at preventing chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By addressing the root causes of gut-related issues, Ombre empowers customers to improve their overall health and well-being with science-backed interventions.

Teambrella Inc. operates a bitcoin-based peer-to-peer insurance platform that facilitates mutual support among users. Founded in 2015 and headquartered in Saint Petersburg, Russia, the company enables participants to cover each other's claims, promoting a communal approach to insurance. Its offerings include deductible supplement coverage for collision insurance, which helps users manage out-of-pocket expenses, and pet insurance that covers veterinary bills. Teambrella aims to transform the traditional insurance model by fostering a system where users align their interests and share risks transparently, enhancing fairness in the claims process.

Nextbiotics is a biotechnology company founded in 2017 and headquartered in Mountain View, California. The company specializes in engineering viruses, specifically bacteriophages, to combat antibiotic-resistant bacteria. Utilizing a platform that combines bacteriophage therapy with CRISPR technology, Nextbiotics develops innovative treatments aimed at reversing antibiotic resistance and addressing various global health challenges. By precisely modulating the microbiome, the company enables medical professionals to effectively treat and prevent infections caused by drug-resistant pathogens.

Shanghai Shihou Network Technology Co., Ltd. is a private company based in Shanghai, China, that operates a mobile gaming and live broadcasting platform. The platform caters to the entertainment sector by providing a diverse selection of online and real-time games, aimed at enhancing user engagement and entertainment experiences. Through its services, Shihou TV connects gamers and viewers, facilitating a dynamic environment for gaming and entertainment.

Teambrella Inc. operates a bitcoin-based peer-to-peer insurance platform that facilitates mutual support among users. Founded in 2015 and headquartered in Saint Petersburg, Russia, the company enables participants to cover each other's claims, promoting a communal approach to insurance. Its offerings include deductible supplement coverage for collision insurance, which helps users manage out-of-pocket expenses, and pet insurance that covers veterinary bills. Teambrella aims to transform the traditional insurance model by fostering a system where users align their interests and share risks transparently, enhancing fairness in the claims process.

HOTEL NIDA is a branded budget hotel internet marketplace. The company's website provides information about trip destinations, hotel pricing, and lodging availability. It allows consumers to look for, compare, and book services after entering pertinent information.

Survios, Inc. is a Los Angeles-based virtual reality company founded in 2012 that specializes in creating immersive gaming experiences. The company emerged from Project Holodeck, an interdisciplinary initiative at the University of Southern California’s Games program, founded by Nathan Burba, James Iliff, and Alexander Silkin. Survios focuses on developing interactive content that utilizes cutting-edge immersive technology to enhance user engagement. Its games are designed to offer a comprehensive sensory experience, incorporating visuals, sounds, and tactile elements to create a dynamic environment for players. Survios aims to push the boundaries of virtual reality gaming and redefine how users interact with digital content.

Lumus, Ltd. specializes in the development and manufacturing of wearable augmented reality (AR) displays, primarily for smart eyewear. Founded in 2000 and based in Ness Ziona, Israel, the company utilizes its patented Light-guide Optical Element (LOE) technology to create transparent displays that seamlessly integrate digital information with the physical world. Lumus's innovative approach allows for lightweight designs, wide fields of view, and true see-through performance, making it a key player in the smart glasses market. Additionally, Lumus provides display development kits to original equipment manufacturers (OEMs), facilitating the creation of advanced AR products that enhance user experience in various applications.

SpaceVR is a virtual reality platform based in San Francisco, California, that enables users to experience space travel through immersive technology. Founded in 2015 by Ryan Holmes, the company utilizes a unique camera system that captures footage from low Earth orbit and streams it to mobile, desktop, and virtual reality devices. This innovative approach allows consumers to engage with space in a firsthand manner, creating opportunities for both entertainment and therapeutic applications. SpaceVR features content such as Orbit Therapy, which aims to alleviate clinical depression and anxiety by simulating the experience of orbiting Earth, and a language learning program designed to accelerate language acquisition. Through its technology, SpaceVR is pioneering new avenues for exploration and learning, making space accessible to a broader audience.

Atheer is a pioneer in augmented reality technology, focusing on enhancing productivity and safety for deskless professionals across various industries. The company's AiR™ platform includes AiR Glasses, which are designed to provide an interactive 3D experience, and the Android-based AiR OS. The AiR Enterprise Suite allows users to collaborate with remote experts through video calls and real-time image annotations, all while maintaining focus on their tasks. By utilizing familiar gestures and voice commands, users can access and engage with essential work information seamlessly. Atheer's open AiR SDK enables developers and businesses to create tailored enterprise applications and workflows, making the platform suitable for high-value tasks in sectors such as industrial, energy, healthcare, insurance, construction, and logistics.

Upload is dedicated to accelerating the success of the VR + AR (XR) industry through inspiring educational experiences.

ElMindA Ltd. focuses on developing diagnostic and treatment tools for brain-related disorders through its innovative Brain Network Activation (BNA) technology. This platform integrates electroencephalography and event-related potential testing with machine learning and advanced algorithms to visualize and assess the brain's neural networks. By capturing electrophysiological patterns related to specific cognitive tasks, ElMindA creates high-resolution, three-dimensional representations of functional neural pathways, which can inform the understanding of various brain functions, including sensory processing, attention, and memory. The technology has applications in conditions such as mild traumatic brain injury, major depressive disorder, Parkinson's disease, and ADHD, aiming to enhance clinical practices in neuroscience. Founded in 2006, ElMindA operates from Herzliya, Israel, with an additional office in Glenview, Illinois.

Sólfar Studios is a virtual reality gaming studio founded by three industry veterans with over 20 years of experience in online worlds, games, and virtual reality. The studio focuses on creating and publishing games across all major VR platforms, including PlayStation's Project Morpheus, Steam VR, and Oculus Rift. Sólfar is dedicated to delivering transformative experiences that evoke visceral emotions, fostering an immersive environment for users. The company maintains a selective approach to talent and collaborators, ensuring a commitment to quality and impactful productions while remaining agile in the ever-evolving gaming landscape.

Yunniao was established in November 2014 to provide regional and city distribution business for the B2B, O2O, chain stores, distributors, brands, manufacturers, LTL network and supply chain management companies besides other customers.